Cargando…
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
T-cell receptor–engineered T-cell therapy and chimeric antigen receptor T-cell therapy are 2 types of adoptive T-cell therapy that genetically modify natural T cells to treat cancers. Although chimeric antigen receptor T-cell therapy has yielded remarkable efficacy for hematological malignancies of...
Autores principales: | Zhang, Jianxiang, Wang, Lingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391541/ https://www.ncbi.nlm.nih.gov/pubmed/30798772 http://dx.doi.org/10.1177/1533033819831068 |
Ejemplares similares
-
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
por: Poorebrahim, Mansour, et al.
Publicado: (2021) -
Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy
por: Bommhardt, Ursula, et al.
Publicado: (2019) -
Emerging Strategies in TCR-Engineered T Cells
por: Wei, Fang, et al.
Publicado: (2022) -
Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
por: Teppert, Karin, et al.
Publicado: (2022) -
TCR-like antibodies in cancer immunotherapy
por: He, Qinghua, et al.
Publicado: (2019)